124 related articles for article (PubMed ID: 24939096)
1. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):333-5. PubMed ID: 24939096
[TBL] [Abstract][Full Text] [Related]
2. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):684-6. PubMed ID: 26114310
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activities of thio-avarol derivatives.
Pejin B; Iodice C; Tommonaro G; De Rosa S
J Nat Prod; 2008 Nov; 71(11):1850-3. PubMed ID: 19007183
[TBL] [Abstract][Full Text] [Related]
4. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
[TBL] [Abstract][Full Text] [Related]
5. Isolation of sesquiterpenoids from sponge Dysidea avara and chemical modification of avarol as potential antitumor agents.
Shen YC; Lu CH; Chakraborty R; Kuo YH
Nat Prod Res; 2003 Apr; 17(2):83-9. PubMed ID: 12713119
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of cytotoxic and mutagenic activity of avarol.
Pejin B; Iodice C; Kojic V; Jakimov D; Lazovic M; Tommonaro G
Nat Prod Res; 2016 Jun; 30(11):1293-6. PubMed ID: 26181496
[TBL] [Abstract][Full Text] [Related]
7. In vitro avarol does affect the growth of Candida sp.
Pejin B; Ciric A; Markovic D; Tommonaro G; Sokovic M
Nat Prod Res; 2016 Sep; 30(17):1956-60. PubMed ID: 26405848
[TBL] [Abstract][Full Text] [Related]
8. The redox couple avarol/avarone in the fight with malignant gliomas: the case study of U-251 MG cells.
Pejin B; Tommonaro G; Glumac M; Jakimov D; Kojic V
Nat Prod Res; 2018 Mar; 32(5):616-620. PubMed ID: 28504009
[TBL] [Abstract][Full Text] [Related]
9. Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4'-leucine-avarone.
Pejin B; Iodice C; Tommonaro G; Bogdanovic G; Kojic V; De Rosa S
Nat Prod Res; 2014; 28(5):347-50. PubMed ID: 24422776
[TBL] [Abstract][Full Text] [Related]
10. Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation.
Amigó M; Schalkwijk J; Olthuis D; De Rosa S; Payá M; Terencio MC; Lamme E
Life Sci; 2006 Nov; 79(25):2395-404. PubMed ID: 16973179
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
12. Effect of avarol and avarone on in vitro-induced microsomal lipid peroxidation.
Belisario MA; Maturo M; Pecce R; De Rosa S; Villani GR
Toxicology; 1992; 72(2):221-33. PubMed ID: 1566281
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models.
Stanojkovic TP; Filimonova M; Grozdanic N; Petovic S; Shitova A; Soldatova O; Filimonov A; Vladic J; Shegay P; Kaprin A; Ivanov S; Nikitovic M
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558184
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of derivatives of the marine quinone avarone.
Bozić T; Novaković I; Gasić MJ; Juranić Z; Stanojković T; Tufegdzić S; Kljajić Z; Sladić D
Eur J Med Chem; 2010 Mar; 45(3):923-9. PubMed ID: 19995673
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors.
Hu Y; Zhang J; Chandrashankra O; Ip FC; Ip NY
Bioorg Med Chem; 2013 Feb; 21(3):676-83. PubMed ID: 23273608
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
[TBL] [Abstract][Full Text] [Related]
17. Effect of avarol, avarone and nine of their natural and synthetic derivatives on microsomal drug-metabolizing enzymes.
Belisario MA; Pecce R; Arena AR; De Giulio A; Strazzullo G; De Rosa S
Toxicol Lett; 1991 Jul; 57(2):183-93. PubMed ID: 1853363
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the activity of the sponge metabolites avarol and avarone and their synthetic derivatives against fouling micro- and macroorganisms.
Tsoukatou M; Maréchal JP; Hellio C; Novaković I; Tufegdzic S; Sladić D; Gasić MJ; Clare AS; Vagias C; Roussis V
Molecules; 2007 May; 12(5):1022-34. PubMed ID: 17873837
[TBL] [Abstract][Full Text] [Related]
20. A new bioactive sesquiterpenoid quinone from the Mediterranean Sea marine sponge Dysidea avara.
Hamed AN; Wätjen W; Schmitz R; Chovolou Y; Edrada-Ebel R; Youssef DT; Kamel MS; Proksch P
Nat Prod Commun; 2013 Mar; 8(3):289-92. PubMed ID: 23678793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]